Literature DB >> 23179960

Progression of β-cell dysfunction in obese youth.

Cosimo Giannini1, Sonia Caprio.   

Abstract

The epidemic of childhood obesity has led to a remarkable increase in the prevalence of type 2 diabetes (T2D) among youth worldwide. The decreasing age at onset of T2D has alarming public health implications. In particular, the longer duration of the disease, as well as the faster onset and progression of T2D related complications, will present a considerable burden for young adults and a strain on public health. Therefore, it is important to understand the pathophysiology of early phases of disruption of glucose tolerance and identify those critical points in which diabetes may be prevented. β-Cell dysfunction has been shown to represent one of the key pathogenetic defects underlying the progression to diabetes in obese youth. In the present review, we describe longitudinal and cross-sectional studies of changes in insulin sensitivity and secretion across the spectrum of glucose tolerance in obese adolescents. Further, the role of ectopic fat accumulation is discussed in relation to its association with both β-cell dysfunction and insulin resistance.

Entities:  

Mesh:

Year:  2013        PMID: 23179960     DOI: 10.1007/s11892-012-0347-7

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  59 in total

Review 1.  Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop.

Authors:  George Alberti; Paul Zimmet; Jonathan Shaw; Zachary Bloomgarden; Francine Kaufman; Martin Silink
Journal:  Diabetes Care       Date:  2004-07       Impact factor: 19.112

Review 2.  The global spread of type 2 diabetes mellitus in children and adolescents.

Authors:  Orit Pinhas-Hamiel; Philip Zeitler
Journal:  J Pediatr       Date:  2005-05       Impact factor: 4.406

3.  Insulin sensitivity, lipids, and body composition in childhood: is "syndrome X" present?

Authors:  S Arslanian; C Suprasongsin
Journal:  J Clin Endocrinol Metab       Date:  1996-03       Impact factor: 5.958

4.  Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease.

Authors:  D J Barker; C Osmond; J Golding; D Kuh; M E Wadsworth
Journal:  BMJ       Date:  1989-03-04

5.  Body-mass index and mortality among 1.46 million white adults.

Authors:  Amy Berrington de Gonzalez; Patricia Hartge; James R Cerhan; Alan J Flint; Lindsay Hannan; Robert J MacInnis; Steven C Moore; Geoffrey S Tobias; Hoda Anton-Culver; Laura Beane Freeman; W Lawrence Beeson; Sandra L Clipp; Dallas R English; Aaron R Folsom; D Michal Freedman; Graham Giles; Niclas Hakansson; Katherine D Henderson; Judith Hoffman-Bolton; Jane A Hoppin; Karen L Koenig; I-Min Lee; Martha S Linet; Yikyung Park; Gaia Pocobelli; Arthur Schatzkin; Howard D Sesso; Elisabete Weiderpass; Bradley J Willcox; Alicja Wolk; Anne Zeleniuch-Jacquotte; Walter C Willett; Michael J Thun
Journal:  N Engl J Med       Date:  2010-12-02       Impact factor: 91.245

6.  Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline.

Authors:  Kenneth C Copeland; Philip Zeitler; Mitchell Geffner; Cindy Guandalini; Janine Higgins; Kathryn Hirst; Francine R Kaufman; Barbara Linder; Santica Marcovina; Paul McGuigan; Laura Pyle; William Tamborlane; Steven Willi
Journal:  J Clin Endocrinol Metab       Date:  2010-10-20       Impact factor: 5.958

7.  Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010.

Authors:  Cynthia L Ogden; Margaret D Carroll; Brian K Kit; Katherine M Flegal
Journal:  JAMA       Date:  2012-01-17       Impact factor: 56.272

8.  Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus.

Authors:  Charlotte M Boney; Anila Verma; Richard Tucker; Betty R Vohr
Journal:  Pediatrics       Date:  2005-03       Impact factor: 7.124

Review 9.  Acute and chronic complications of type 2 diabetes mellitus in children and adolescents.

Authors:  Orit Pinhas-Hamiel; Philip Zeitler
Journal:  Lancet       Date:  2007-05-26       Impact factor: 79.321

Review 10.  Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications.

Authors:  Elisa Fabbrini; Shelby Sullivan; Samuel Klein
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

View more
  3 in total

1.  Metabolic Risk Factors and Type 2 Diabetes Incidence in American Indian Children.

Authors:  Kevin M Wheelock; Madhumita Sinha; William C Knowler; Robert G Nelson; Gudeta D Fufaa; Robert L Hanson
Journal:  J Clin Endocrinol Metab       Date:  2016-02-25       Impact factor: 5.958

2.  Impaired fasting glucose and impaired glucose tolerance in children and adolescents with overweight/obesity.

Authors:  P Di Bonito; L Pacifico; C Chiesa; G Valerio; E Miraglia Del Giudice; C Maffeis; A Morandi; C Invitti; M R Licenziati; S Loche; G Tornese; F Franco; M Manco; M G Baroni
Journal:  J Endocrinol Invest       Date:  2016-11-16       Impact factor: 4.256

3.  Yields and costs of recruitment methods with participant phenotypic characteristics for a diabetes prevention research study in an underrepresented pediatric population.

Authors:  Kiley B Vander Wyst; Micah L Olson; Elva Hooker; Erica G Soltero; Yolando P Konopken; Colleen S Keller; Felipe G Castro; Allison N Williams; Arlene D R Fernández; Donald L Patrick; Stephanie L Ayers; Houchun H Hu; Armando Peña; Janiel Pimentel; William C Knowler; Gabriel Q Shaibi
Journal:  Trials       Date:  2020-08-14       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.